Here's a comprehensive overview of the procedures, required documents, and key considerations for Class IV medical device registration under the Hong Kong Medical Device Administrative Control System (MDACS):
MDACS is a voluntary system administered by the Medical Device Division (MDD) under Hong Kong’s Department of Health.
Devices are classified into Classes I–IV, with Class IV representing the highest risk (e.g., implantable defibrillators, heart valves).
Only Class II, III, and IV devices need to be listed for MDACS participation.
Listing is required for supply to public hospitals and government tenders.
| Step | Action |
|---|---|
| 1 | Appoint a Local Responsible Person (LRP) in Hong Kong. |
| 2 | Ensure the device is approved in at least one Reference Country (e.g., CE, FDA, TGA). |
| 3 | Prepare the required technical documentation and administrative forms. |
| 4 | Submit the application (Form MD4 and all supporting documents) to the Medical Device Division. |
| 5 | Await acknowledgment and potential requests for further information. |
| 6 | Upon acceptance, the device will be listed on the MDACS Device List. |
| 7 | Comply with post-market obligations (e.g., incident reporting, updates). |
✅ Form MD4: Application for Listing Class II/III/IV Medical Devices
✅ LRP registration confirmation (Form MD1 previously submitted)
✅ Letter of Authorization from manufacturer to the LRP
✅ Copy of Business Registration Certificate of the LRP
✅ Reference Country Approval (e.g., CE Certificate, FDA 510(k)/PMA, TGA, etc.)
✅ Manufacturer’s Declaration of Conformity
✅ Device Description and intended use
✅ Design and Manufacturing Information
✅ Risk Analysis File (e.g., per ISO 14971)
✅ Clinical Evaluation Report (e.g., MEDDEV 2.7/1 Rev. 4 or MDR Annex XIV)
✅ Quality Management System Certificate (e.g., ISO 13485)
✅ Labeling and Instructions for Use (IFU) (in English or Chinese)
✅ Post-market Surveillance Plan
✅ Product Photos, Brochure, and Marketing Materials
Must be based in Hong Kong
Official liaison with MDD and responsible for post-market surveillance
Only devices approved in one or more of the designated countries are eligible:
EU (CE-marked under MDR/IVDR)
USA (FDA 510(k) or PMA)
Australia (TGA)
Canada (Health Canada MDL)
Japan (PMDA/MHLW)
All documents must be in English or Chinese
Labels and IFU must comply with Hong Kong standards
While there is no expiry for listing, the MDD must be notified of:
Design changes
Labeling/IFU changes
Change in LRP or manufacturer details
Market withdrawals or safety notices
Report adverse incidents to the MDD
Maintain vigilance and risk control systems
Submit all documents to:
Medical Device Division (MDD)
Department of Health
Units 2-3, 11/F, Energy Plaza, 92 Granville Road
Tsim Sha Tsui East, Kowloon, Hong Kong
Currently, there is no government fee for registration.
Would you like a downloadable checklist or template set (e.g., Form MD4 sample, Authorization Letter, Clinical Evaluation Report outline)?

Whatsapp or Wechat:+86 15816864648;email address:hito.lin@grzan.cn